SNAP-8

Quickstart Highlights

SNAP-8 (acetyl octapeptide-3) is an eight-amino-acid cosmetic peptide, an elongated form of Argireline, that mimics part of the SNAP-25 protein and dampens the signaling that drives facial muscle contraction. It is used in topical serums to soften expression lines such as crow’s feet, forehead lines and the glabella, with manufacturer data reporting reduced wrinkle severity at 28 days. This educational page presents a topical-only preparation: dissolve the 10 mg vial in 2.0 mL bacteriostatic water to make a 5 mg/mL stock, blend the stock into a preserved serum base to 0.1% (1 mg/mL), and apply a thin layer to expression lines morning and evening. No injectable use exists.

• Route: Topical only. Amino Labs supplies SNAP-8 for topical use; no injection, syringe or pen settings apply.
• Stock solution: Add 2 mL bacteriostatic water to the 10 mg vial → 5 mg/mL stock.
• Finished strength: Blend the stock into a preserved serum base to 0.1% (1 mg/mL); 10 mg makes 10 mL of serum.
• Storage: Lyophilized: freeze at −20 °C (−4 °F); stock and finished serum refrigerated at 2–8 °C (35.6–46.4 °F), use within 28 days.

Protocol Overview

Concise summary of the topical preparation and twice-daily application.

• Goal: Soften expression lines (crow’s feet, forehead, glabella) by reducing the force of facial muscle contraction through interference with SNARE-complex assembly at the neuromuscular junction.
• Schedule: Thin-layer topical application to clean, dry skin morning and evening, continuous, with results judged at 28 days.
• Strength: 0.1% (1 mg/mL) finished serum as the standard, with 0.05% (0.5 mg/mL) as a lower strength for reactive skin and 0.2% (2 mg/mL) as the upper research-vial strength.
• Preparation: 2 mL stock (5 mg/mL) blended into 8 mL serum base for 10 mL at 0.1%.
• Storage: Lyophilized frozen; stock and serum refrigerated at 2–8 °C, used within 28 days.
• Evidence: Manufacturer in-vitro and small cosmetic in-vivo claims plus read-across from Argireline; there is no independent RCT of SNAP-8 alone and no injectable data of any kind, so confidence is medium for the topical use level and high that no injectable route exists.

Application Protocol

Topical application approach based on manufacturer cosmetic data and research-community conventions for diluting a 10 mg vial.

• Stock solution: 10 mg vial + 2 mL bacteriostatic water = 5 mg/mL (0.5%). This fits the 3 mL vial and is the concentrate, not the product applied to skin.
• Standard serum (0.1%): 2 mL stock + 8 mL preserved serum base = 10 mL at 1 mg/mL, the mid-point of the research-vial range.
• Lower strength (0.05%): 1 mL stock + 9 mL serum base = 0.5 mg/mL; sources describe starting at the lower end if irritation occurs.
• Upper strength (0.2%): 2 mL stock + 3 mL serum base = 2 mg/mL, the top of the research-vial dilution range.
• Application: A thin layer to expression lines (crow’s feet, forehead, glabella) morning and evening on clean, dry skin, before moisturiser.
• Cycle: Continuous daily use with no cycling; sources judge results at 28 days, and the effect is reversible on stopping.
• Cosmetic-industry comparison: The commercial 3–10% usage rate refers to the manufacturer’s 0.05% stock solution (Lipotec Solution C), which works out to only 0.0015–0.005% pure peptide (15–50 mg per liter) in a finished product; the research-vial dilutions above (0.05–0.2%) are roughly 10–130 times more concentrated.

Storage Instructions

Proper storage preserves product quality and efficacy.

• Lyophilized (powder): Store at −20 °C (−4 °F) or refrigerated at 2–8 °C (35.6–46.4 °F), protected from light and moisture.
• Stock solution (in bacteriostatic water): Refrigerate at 2–8 °C (35.6–46.4 °F), away from light, and use within 28 days; do not freeze.
• Finished serum: Refrigerate at 2–8 °C (35.6–46.4 °F) in a sealed dropper or airless pump bottle and use within 28 days when blended into a preserved base; in an unpreserved base, treat it as a fresh cosmetic and use within a few weeks at most.
• Allow the vial to reach room temperature before opening to minimize condensation uptake.

Important Notes

Practical considerations for consistency and safety.

• Topical only: Amino Labs supplies SNAP-8 for topical use. There is no injectable route and no injectable safety data of any kind; no syringe or pen settings apply, and the research-vial format does not imply injection.
• What 3–10% means: In cosmetic-industry sources this is the usage rate of the manufacturer’s 0.05% stock solution in a finished product, not pure peptide. Read correctly, 3–10% of a 0.05% solution is 0.0015–0.005% pure peptide, which would spread 10 mg across roughly 200–670 mL of finished product; the research-vial dilutions on this page (0.05–0.2%) are far stronger and are a community convention, not a validated use level.
• Regulatory: Acetyl octapeptide-3 is an unrestricted cosmetic ingredient (INCI) in Canada and the United States; it is not a drug and carries no approved therapeutic claim. Not approved by Health Canada or the FDA as a drug; the research vial is sold for research use only.
• Evidence caveat: Efficacy figures (up to 63% reduction in eye-wrinkle severity at 28 days; about 30% more active than Argireline in vitro) are manufacturer claims. The only peer-reviewed human studies are co-formulated microneedle patches, and no independent trial of SNAP-8 alone exists.
• Penetration: SNAP-8 is hydrophilic and skin penetration is uncertain; the human studies used penetration enhancers or microneedle patches, so results from a simple leave-on serum may be modest.
• Use bacteriostatic water, not sterile, distilled or tap water, for the stock; dissolve in no more than 2 mL inside the 3 mL vial and transfer to a larger bottle for the final dilution.
• Patch test on the inner forearm or behind the ear for 24 hours before facial use, keep the serum away from the eyes, and stop if burning or persistent redness develops.
• Blend at room temperature below 40 °C, adding the peptide stock at the end of any formulation step, and label every batch with the strength and mixing date.

How This Works

SNAP-8 is an eight-amino-acid elongation of Argireline (acetyl hexapeptide-8) designed to mimic the N-terminal region of SNAP-25, one of the proteins that assemble into the SNARE complex required for synaptic vesicles to dock and release neurotransmitter. By competing with native SNAP-25 for a place in that complex, SNAP-8 destabilises SNARE assembly and reduces the release of acetylcholine and catecholamines at the neuromuscular junction, so the facial muscles beneath expression lines contract less forcefully and the overlying wrinkles soften. Unlike botulinum toxin, it does not cleave SNARE proteins, so the effect is mild, fully reversible and depends on continued topical exposure. The manufacturer reports up to 63% reduction in eye-wrinkle severity after 28 days and about 30% greater in-vitro activity than Argireline, but there is no independent trial of SNAP-8 alone, the peptide is hydrophilic with uncertain skin penetration, and the only peer-reviewed human data come from co-formulated microneedle patches.

Potential Benefits & Side Effects

Observations from manufacturer cosmetic data, co-formulated patch studies and Argireline read-across.

Potential Benefits:

• Reduced depth and severity of expression wrinkles (crow’s feet, forehead) after about 28 days in manufacturer studies.
• Marketed as a topical alternative to neuromodulator injections, about 30% more active than Argireline in vitro (manufacturer data).
• Smoother skin texture when combined with other peptides and humectants in a serum base (cosmetic formulation reports).
• Good tolerability profile suited to daily cosmetic use; a 2024 dissolving-microneedle patch trial (24 subjects, 28 days) in which SNAP-8 was one of several actives reported no adverse effects.

Potential Side Effects:

• Mild, transient stinging, redness or irritation, especially at higher concentrations or near the eyes.
• Contact reaction in sensitive skin; a patch test is advised before facial use.
• No systemic effects documented for topical use.
• Injectable use has no safety data; local erythema and bruising were reported by the single outlier site that describes it, and it is not a convention.

Lifestyle Factors

Complementary habits for expression-line outcomes.

• Apply daily sunscreen; UV exposure drives the collagen loss that deepens expression lines and will outpace any peptide effect.
• Layer the serum first on clean, dry skin and follow with a moisturiser to limit water loss from the skin.
• Keep a consistent twice-daily routine; the SNAP-8 effect is reversible and depends on continued exposure.
• Avoid applying immediately after harsh exfoliants or retinoids if the skin is reactive, to reduce stinging.
• Take standardized photographs in the same light at baseline and at 28 days to judge response objectively.

Application Technique

Practical guidance for consistent topical use.

• Cleanse and fully dry the skin; apply to clean, dry skin before any moisturiser or oil-based product.
• Dispense a thin layer onto expression-line areas only (crow’s feet, forehead, glabella) and pat in with a fingertip; a small amount covers the area.
• Keep the product away from the eyes and lash line; if it migrates into the eye, rinse with water.
• Wait a minute or two for absorption, then follow with moisturiser and, in the morning, sunscreen.
• Apply morning and evening every day; consistency matters more than quantity, and the effect fades once application stops.
• If stinging or redness persists beyond the first few applications, switch to the 0.05% dilution or stop.

Recommended Source

We recommend Amino Labs for high-purity SNAP-8 (10 mg vials).

Note: Product availability and specifications subject to change. Verify current product details on supplier website.

Shop at Amino Labs